Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinol
about
United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthoodGH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.Bridging the gap: metabolic and endocrine care of patients during transitionTreatment of adult growth hormone deficiency: who, why and how? A reviewPrevalence of hypopituitarism after intracranial operations not directly associated with the pituitary glandStatement by the Growth Hormone Research Society on the GH/IGF-I axis in extending health span.A long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adultsThe effect of growth hormone (GH) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real-life data from the NordiNet® International Outcome Study.Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysisThe decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors.A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiencyLong-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults studyEfficacy of growth hormone therapy in adults with childhood-onset growth hormone deficiency.Traumatic brain injury causes long-term reduction in serum growth hormone and persistent astrocytosis in the cortico-hypothalamo-pituitary axis of adult male rats.Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes.The use of neuroimaging for assessing disorders of pituitary development.Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency.Extracellular water and blood pressure in adults with growth hormone (GH) deficiency: a genotype-phenotype association study.Prevalence of GH and other anterior pituitary hormone deficiencies in adults with nonsecreting pituitary microadenomas and normal serum IGF-1 levels.Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiencyGrowth hormone replacement therapy: transition from adolescence to adulthoodOverweight/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency.Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®.Evidence of hormone resistance in a pseudo-pseudohypoparathyroidism patient with a novel paternal mutation in GNAS.Glucagon stimulation testing in assessing for adult growth hormone deficiency: current status and future perspectives.High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injuryHypopituitarism in Traumatic Brain Injury-A Critical Note.Adult growth hormone deficiency: current concepts.Safety, pharmacokinetic and pharmacodynamic properties of TV-1106, a long-acting GH treatment for GH deficiency.Diagnosing growth hormone deficiency in adults.Gender-, age- and time-dependent dosing of growth hormone in adults - real-world data from a decade of clinical practice in Germany.Rationale and design of PATRO Adults, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope(®) for the treatment of adult patients with growth hormone deficiencyNovel serum protein biomarkers indicative of growth hormone doping in healthy human subjectsAssociations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial RadiotherapyHypothesis: neuroendocrine mechanisms (hypothalamus-growth hormone-STAT5 axis) contribute to sex bias in pulmonary hypertension.Effects of growth hormone withdrawal in obese premenopausal womenAn audit of the management of childhood-onset growth hormone deficiency during young adulthood in Scotland.Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency.Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therap
P2860
Q21245400-3B700C25-76B5-4CCE-A9B8-FCD2F4E1F174Q26777290-7E4B7150-2592-4BA0-973A-DD8B2746FBE0Q28069698-DB2B482E-8876-4378-B287-C1790999F83DQ28278957-B9F063BE-5ECD-43D7-9609-4BCE51B972EFQ30430156-06A6D259-6022-46C4-94FB-82EDCEB53FB6Q30448722-2CDC3626-E93B-422D-845F-613E9F000C03Q30540160-258C7A26-8B50-4517-A646-CCFFCC351DD5Q31136431-754BA2F0-E2D0-435C-A7FA-203721F5BF70Q33569898-B3D3F909-549B-4DA8-9D05-53240C93F074Q33633368-A3872D03-20AD-4022-BC80-E6244CF6054EQ33656411-41554218-EF60-4E2A-AB6A-E29BC9C6FB5AQ33726068-107BA72A-7093-4DE6-AEF4-6A9329B10A78Q33726968-C3622CB1-60C4-4AB9-9D9C-BD3F3A9CE9D2Q33772460-A30368B8-5761-445C-82D2-85067D21F098Q34004910-80BAA7A3-9857-4845-98C2-C64FD646FFADQ34033813-6D447BE3-C1D9-49A6-A333-9EFC99D419D6Q34080011-A8A3087C-91E5-484C-8647-7248C15ABFAEQ34090179-44CFFB62-6BA8-4368-8F98-6AF6AF4E021FQ34192082-1622DF16-79F3-4FBC-AF15-00BB67035EA7Q34396589-FD43DBD2-78B1-4D59-9F47-CDD51FF9EE31Q34423608-757B2BDE-623B-4B6C-BF5A-5D8D5BC2E497Q34628461-CFE47C3F-6D76-44BB-B53A-66444F64144EQ34714880-3ECC779C-03CC-487B-A234-F501C080CC37Q34751754-41A2977F-DC8B-4016-9885-9BFBB41CC674Q35684662-D8514249-EB58-4D61-8433-09976B170ABBQ35740384-74046A30-B1B4-4B05-A69C-4B5729893B72Q35902224-03DD012D-9900-49DE-A9BF-E392E1EACB6CQ35943964-29A0A4B6-401E-4177-807E-5103FB968066Q36096814-28D850CF-26CB-4257-BB6E-60CD3062E544Q36140969-BEB42136-1A0E-415A-81F1-DAD571F833B5Q36301950-6CADB498-296A-44C7-9FD1-CF5B2A86870CQ36328086-E6226C68-82DF-40A7-9D93-43E6A6E9BF34Q36453050-0DD56943-CED6-4C43-9496-3614C3DC8283Q36520147-4166E0F1-3395-4543-B2DE-B448691C6F5DQ36568290-5C19ADA4-7928-4B64-A653-56DD53B48008Q36652243-2EFBAE18-CD4E-4F76-B6C6-3B2C958E5AACQ36691443-53469B0E-ACE8-4A75-BED8-03495C68CD27Q36716108-62D34053-7880-4EA2-B39F-F18320131089Q36755284-8CBE7824-FC2D-4667-BFE0-88CC8917C307Q36811087-EB1DB232-A9B9-4B70-B95E-3DB41039498F
P2860
Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinol
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Consensus guidelines for the d ...... European Society of Endocrinol
@en
Consensus guidelines for the d ...... European Society of Endocrinol
@nl
type
label
Consensus guidelines for the d ...... European Society of Endocrinol
@en
Consensus guidelines for the d ...... European Society of Endocrinol
@nl
prefLabel
Consensus guidelines for the d ...... European Society of Endocrinol
@en
Consensus guidelines for the d ...... European Society of Endocrinol
@nl
P356
P1476
Consensus guidelines for the d ...... European Society of Endocrinol
@en
P2093
2007 GH Deficiency Consensus Workshop Participants
Ken K Y Ho
P304
P356
10.1530/EJE-07-0631
P577
2007-12-01T00:00:00Z